Meeting in Vietnam Discusses Tobacco Prevention and Control

Regulations by 2FIRSTS.ai
Nov.24.2023
Meeting in Vietnam Discusses Tobacco Prevention and Control
Vietnam aims to enhance tobacco control efforts amid rising smoking-related deaths and economic losses, urging strict regulations on e-cigarette usage.

In recent news, according to Vietnamplus, the Ministry of Information and Communications of Vietnam, in collaboration with the Ministry of Health's Tobacco Control Fund, organized a meeting in Hanoi on Thursday, November 23. The objective of the meeting was to enhance the dissemination capabilities for the prevention and control of tobacco hazards.

 

According to data from the Tobacco Control Fund, globally, 8 million people die from smoking each year, with around 1 million deaths attributed to passive smoking. In Vietnam, this number stands at 40,000. The World Health Organization (WHO) estimates that the economic loss caused by tobacco worldwide amounts to a staggering $1.4 trillion annually. In Vietnam, the cost of combating the negative impacts of tobacco accounts for approximately 1% of the country's GDP.

 

According to a tobacco usage survey conducted in 2022 among teenagers aged 13 to 15, the prevalence of e-cigarette use in this age group is 3.5%, which represents a significant increase compared to the 2.6% reported in 2019.

 

Dr. Nguyên Thi Thu Huong, a leading figure in tobacco control funding, has suggested not approving pilot projects for heated tobacco, due to the rising number of young people using tobacco, particularly heated tobacco. The aim is to prevent e-cigarettes from entering the Vietnamese market under the guise of heated tobacco.

 

Meanwhile, Director Nguyen Chung Nguyen of Hanoi Bai Mai Hospital's Poison Control Center has proposed an immediate ban on the circulation of e-cigarettes in Vietnam.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.
Dec.10 by 2FIRSTS.ai
China Further Tightens E-Cigarette Capacity and Investment Controls, Supply Chain Faces Stronger Regulation and Accelerated Shakeout
China Further Tightens E-Cigarette Capacity and Investment Controls, Supply Chain Faces Stronger Regulation and Accelerated Shakeout
China is tightening controls over e-cigarette production capacity and investment as regulators move to curb disorderly competition and address oversupply risks, a new policy framework released on December 25 shows, signaling stronger oversight and a faster shakeout across the country’s e-cigarette supply chain, according to first-hand reporting by 2Firsts.
Dec.25
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
Imperial Brands’ blu adds “Creamy Tobacco” flavour, rolling out across device kits and pod products
Imperial Brands’ blu adds “Creamy Tobacco” flavour, rolling out across device kits and pod products
Imperial Brands’ vaping brand blu has outlined its flavour roadmap for 2026 on its official website, adding a new “Creamy Tobacco” flavour that has been rolled out across the rechargeable blu bar kit and its compatible blu kit pods. The brand describes the flavour as offering a more velvety tobacco taste.
Dec.19